Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 2
1952 1
1953 3
1954 6
1955 12
1957 7
1961 6
1963 2
1964 6
1965 5
1966 4
1967 1
1968 3
1970 1
1973 2
1974 1
1975 1
1977 2
1978 1
1981 4
1982 1
1983 2
1984 5
1985 1
1986 2
1987 1
1988 4
1989 2
1990 3
1991 2
1994 2
1996 1
1997 1
1998 1
2000 1
2001 1
2003 1
2012 1
2013 4
2014 4
2015 4
2016 3
2017 2
2018 3
2019 2
2020 9
2021 5
2022 4
2023 4
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Results by year

Filters applied: . Clear all
Page 1
[Primary hepatic amyloidosis].
Pacini F, Berni G, Ghetti A, Morettini A. Pacini F, et al. Among authors: morettini a. Riv Crit Clin Med. 1968;68:Suppl 6:1188+. Riv Crit Clin Med. 1968. PMID: 4916730 Review. Italian. No abstract available.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study.
Vivarelli E, Matucci A, Lucenteforte E, Bormioli S, Virgili G, Trotta M, Spinicci M, Bartoloni A, Zammarchi L, Peris A, Pieralli F, Lavorini F, Fontanari P, Morettini A, Nozzoli C, Poggesi L, Rossi O, Annunziato F, Almerigogna F, Vultaggio A. Vivarelli E, et al. Among authors: morettini a. Panminerva Med. 2023 Dec;65(4):473-478. doi: 10.23736/S0031-0808.21.04523-7. Epub 2022 Mar 11. Panminerva Med. 2023. PMID: 35274908
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study.
Vannucchi AM, Sordi B, Morettini A, Nozzoli C, Poggesi L, Pieralli F, Bartoloni A, Atanasio A, Miselli F, Paoli C, Loscocco GG, Fanelli A, Para O, Berni A, Tassinari I, Zammarchi L, Maggi L, Mazzoni A, Scotti V, Falchetti G, Malandrino D, Luise F, Millotti G, Bencini S, Capone M, Piccinni MP, Annunziato F, Guglielmelli P; RUXO-COVID Study Group. Vannucchi AM, et al. Among authors: morettini a. Leukemia. 2021 Apr;35(4):1121-1133. doi: 10.1038/s41375-020-01018-y. Epub 2020 Aug 19. Leukemia. 2021. PMID: 32814839 Free PMC article. Clinical Trial.
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy.
Lagi F, Trevisan S, Piccica M, Graziani L, Basile G, Mencarini J, Borchi B, Menicacci L, Vaudo M, Scotti V, Fabbri A, Bandini G, Tozzetti C, Berni A, Aiezza N, Pestelli G, Turchi V, Pignone AM, Poggesi L, Nozzoli C, Morettini A, Rossolini GM, Bartoloni A. Lagi F, et al. Among authors: morettini a. Int J Infect Dis. 2021 Jul;108:231-236. doi: 10.1016/j.ijid.2021.04.065. Epub 2021 Apr 24. Int J Infect Dis. 2021. PMID: 33901656 Free PMC article.
A prediction rule for early recognition of patients with candidemia in Internal Medicine: results from an Italian, multicentric, case-control study.
Sozio E, Pieralli F, Azzini AM, Tintori G, Demma F, Furneri G, Sbrana F, Bertolino G, Fortunato S, Meini S, Bragantini D, Morettini A, Nozzoli C, Menichetti F, Concia E, Tascini C; GISA/FADOI Candida Study Group. Sozio E, et al. Among authors: morettini a. Infection. 2018 Oct;46(5):625-633. doi: 10.1007/s15010-018-1162-0. Epub 2018 Jun 9. Infection. 2018. PMID: 29949088
SSRIs in the course of COVID-19 pneumonia: Evidence of effectiveness of antidepressants on acute inflammation. A retrospective study.
Fei L, Bozza B, Melani G, Righi L, Santarelli G, Boy OB, Benedetti D, Falone A, Flaccomio D, Giuranno G, Martelli M, Merola P, Moretti S, Ndoci E, Pecoraro V, Siviglia S, Berni A, Fanelli A, Giovagnini E, Morettini A, Nozzoli C, Para O, Rostagno C, Tozzetti C. Fei L, et al. Among authors: morettini a. Hum Psychopharmacol. 2024 Jan;39(1):e2887. doi: 10.1002/hup.2887. Epub 2023 Dec 7. Hum Psychopharmacol. 2024. PMID: 38059650
138 results